Day: June 19, 2024

Canadian North Resources Inc. Announces Results of Annual General Meeting

Canadian North Resources Inc. Announces Results of Annual General Meeting

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) — Canadian North Resources Inc. (“CNRI” or “the Company,” TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to announce the voting results for the election of its Board of Directors at its Annual and Special Meeting of Shareholders held on June 18, 2024, in Mississauga, Ontario. A total of 75,369,669 common shares were voted at the Meeting, representing 65.81% of the common shares outstanding (114,527,617). Shareholders approved the re-election of all Directors as listed in the Management Information Circular dated May 28, 2024, and the reappointment of MNP LLP, Chartered Professional Accountants, as auditors of the Company at a remuneration to be fixed by the directors. In addition, the resolution to ratify and approve the Company’s Stock Option Plan was passed. Refer to the Table...

Continue reading

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced the appointment of Svetlana Lucas, Ph.D., to Jasper’s Board of Directors (the Board), effective as of June 18, 2024. Separately, Anna French, D. Phil., stepped down from the Board, effective as of June 18, 2024. “We are pleased to welcome Svetlana, an experienced and accomplished biopharmaceutical executive, to our Board,” said Thomas Wiggans, Chairperson of Jasper’s Board. “Svetlana has led several significant partnerships with large pharma and has particular...

Continue reading

Stingray Announces Reduction of Board Nomination Rights for Telesystem Investors

Stingray Announces Reduction of Board Nomination Rights for Telesystem Investors

MONTREAL, June 19, 2024 (GLOBE NEWSWIRE) — Stingray Group Inc. (“Stingray” or the “Corporation”) (TSX: RAY.A; RAY.B) today announces that it has been informed that the 5,000,000 multiple voting shares of the Corporation (“Multiple Voting Shares”) held by Télésystème Média Can Inc. have been voluntarily converted (the “Conversion Event”) into 5,000,000 subordinate voting shares of the Corporation (“Subordinate Voting Shares”). Following the Conversion Event, the Telesystem Investors (as that term is defined in the Nomination Rights Agreement) are now entitled to designate one member (down from three members) of the Board of Directors of the Corporation (the “Board”) pursuant to the nomination rights agreement dated as of June 3, 2015, as amended, between the Corporation, Eric Boyko, 8242003 Canada Inc., 8978832 Canada Inc., Boyko...

Continue reading

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and equipment used in immunohistochemistry for the diagnostic, research, industrial, university and hospital industries, with a focus on clinical pathology and oncology end markets. The acquisition of DCS strengthens Calibre Scientific’s expanding product and service portfolio throughout the DACH region. Founded in 1992 and based in Hamburg, Germany, DCS has established a leading market position in immunohistochemistry, supplying a complete portfolio of primary antibodies, secondary reagents, detection systems, and automation systems to laboratories, hospitals and universities in the DACH region. With this acquisition,...

Continue reading

Cloud Gaming Market to Grow at 45.8% CAGR by 2031 | Skyquest Technology

Cloud Gaming Market to Grow at 45.8% CAGR by 2031 | Skyquest Technology

Westford USA, June 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the cloud gaming market will attain a value of USD 20940 million by 2031, with a CAGR of 45.8% during the forecast period (2024-2031). Cloud gaming has redefined the gaming industry with its introduction of online gaming without the need for hardware. This innovation has resonated with gamers across the world and allows them to spend and worry less on hardware as well as about the fact that their hardware can support new games with every new release. It has improved the quality of games in terms of easy access and affordability. Cloud gaming also helps the players to build their personal library of games, offer them the chance to save their progress, and gain instant access to their accounts. Download a detailed overview: https://www.skyquestt.com/sample-request/cloud-gaming-market Browse...

Continue reading

Subsea 7 S.A. Conference Call Notification - Q2 2024 Results

Subsea 7 S.A. Conference Call Notification – Q2 2024 Results

 Luxembourg – 20 June 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) will publish its second quarter results for the period ended 30 June 2024 on Thursday 25 July 2024 at 08:00 CET. A conference call and simultaneous webcast for the investment community will be held on Thursday 25 July 2024 at 13:00 CET. From 08:00 CET the results announcement and the presentation to be reviewed during the conference call and webcast will be available on the Subsea7 website: www.Subsea7.com Conference call registration:Call:  https://register.vevent.com/register/BI3b41ee08345f486b8d18c074b312bd5eWebcast: https://edge.media-server.com/mmc/p/af8ir6ef/ ************************************************************************************************************************Subsea7 creates sustainable value by delivering the offshore energy transition solutions...

Continue reading

FTAI Aviation Announces Early Tender Results for its 9.750% Senior Notes Due 2027

FTAI Aviation Announces Early Tender Results for its 9.750% Senior Notes Due 2027

NEW YORK, June 19, 2024 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI), a Cayman Islands exempted company (the “Company” or “FTAI”) announced today the early tender results of the previously announced cash tender offer (the “Tender Offer”) to purchase for cash up to $300,000,000 aggregate principal amount (the “Tender Cap”) of Fortress Transportation and Infrastructure Investors LLC’s (“FTAI LLC”) outstanding 9.750% Senior Notes due 2027 (the “2027 Notes”), on the terms and conditions set forth in FTAI LLC’s Offer to Purchase, dated June 3, 2024, as amended on June 3, 2024 and June 17, 2024 (the “Offer to Purchase”). Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase. According to D.F. King & Co., Inc., the tender and information agent for the Tender Offer,...

Continue reading

Philips completes cancellation of 4.4 million shares

Philips completes cancellation of 4.4 million shares

June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips’ current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares. More information is available here.  For further information, please contact: Ben ZwirsPhilips External RelationsTel.: +31 6 1521 3446E-mail: ben.zwirs@philips.com Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail: dorin.danu@philips.com About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through...

Continue reading

Green Thumb Grows its Retail Footprint in Florida with the Opening of RISE Dispensary New Port Richey, its 17th Retail Location in the Sunshine State, on June 21

Green Thumb Grows its Retail Footprint in Florida with the Opening of RISE Dispensary New Port Richey, its 17th Retail Location in the Sunshine State, on June 21

CHICAGO and VANCOUVER, British Columbia, June 19, 2024 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Dispensary New Port Richey, the Company’s 17th retail location in Florida and 94th nationwide, will open on June 21. The dispensary, located at 6213 State Road 54, New Port Richey, FL, 34653, will offer medical patients a diverse collection of cannabis products, including RYTHM premium flower and full spectrum vapes, Dogwalkers pre-rolls, Good Green flower, Dr. Solomon’s tinctures and &Shine flower, pre-rolls, vapes and chews. RISE New Port Richey will host a grand opening event on July 26, where profits from the day will be donated to the Warrior Wellness Program. “We are...

Continue reading

White Gold Corp. Announces Fully Funded 2024 Exploration Program on its District Scale Land Package in Yukon, Canada

White Gold Corp. Announces Fully Funded 2024 Exploration Program on its District Scale Land Package in Yukon, Canada

Figure 1 District Map Showing 2024 Exploration Projects Figure 1 District Map Showing 2024 Exploration Projects Figure 2 Betty DDH Targets Figure 2 Betty DDH Targets Figure 3 QV Soil Anomaly – DDH Target Figure 3 QV Soil Anomaly – DDH Target TORONTO, June 19, 2024 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce plans for its fully funded 2024 exploration program on its district scale 315,000-hectare land package, representing approximately 40% of the emerging White Gold District (the “District”) in Yukon, Canada. The Company’s district scale land package hosts it flagship White Gold Project comprised of 16 million tonnes averaging 2.23 g/t Au for 1,152,900 ounces of gold in the Indicated Resource category and 19 million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.